Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145460

Pw145460 View Pathway
drug action

Solifenacin Drug Metabolism Action Pathway

Homo sapiens

PW127978

Pw127978 View Pathway
drug action

Solifenacin M3 Bladder Muscle Relaxation Action Pathway

Homo sapiens
Solifenacin is a muscarinic antagonist with antispasmodic properties used to treat urge urinary incontinence, urgency, and urinary frequency associated with an overactive bladder. It can be found under the brand name Vesicare. It has a long duration of action as it is usually taken once daily. Solifenacin is a competitive muscarinic receptor antagonist. Solifenacin's antagonism of the M3 receptor prevents contraction of the detrusor muscle, while antagonism of the M2 receptor may prevent contraction of smooth muscle in the bladder. Solifenacin works to decrease bladder activity by inhibiting contraction of the smooth muscle wall surrounding the bladder. As a potent and selective muscarinic receptor antagonist, solifenacin acts specifically at the M3 receptor site. Possible side effects of using solifenacin may include dry mouth, headache, dizziness, and vertigo. Solifenacine is administered as an oral tablet.

PW176177

Pw176177 View Pathway
metabolic

Solifenacin Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Solifenacin are predicted with biotransformer.

PW127941

Pw127941 View Pathway
drug action

Solriamfetol Action Pathway

Homo sapiens
Solriamfetol, also known as Sunosi, is a dopamine and norepinephrine reuptake inhibitor (DNRI). This drug is indicated for the daytime treatment of sleepiness associated with narcolepsy or obstructive sleep apnea. Solriamfetol was given FDA approval in 2019. Solriamfetol weakly binds to dopamine and norepinephrine transporters but not serotonin transporters. Those transporters are called sodium-dependent dopamine transporter and sodium-dependent noradrenaline transporter. This makes more dopamine and noradrenaline available in the synapses of the brain. In consequence, the postsynaptic has more of those neurotransmitters available. Norepinephrine and dopamine are important neurotransmitters in sleep-wake regulation. This drug is available as oral tablets.

PW146888

Pw146888 View Pathway
drug action

Solriamfetol Drug Metabolism Action Pathway

Homo sapiens

PW176232

Pw176232 View Pathway
metabolic

Solriamfetol Predicted Metabolism Pathway

Homo sapiens
Metabolites of Solriamfetol are predicted with biotransformer.

PW145978

Pw145978 View Pathway
drug action

Somatostatin Drug Metabolism Action Pathway

Homo sapiens

PW124340

Pw124340 View Pathway
metabolic

Some path

Homo sapiens

PW122143

Pw122143 View Pathway
signaling

Sonic Hedgehog (Shh)

Mus musculus

PW091415

Pw091415 View Pathway
signaling

Sonic Hedgehog (Shh) Pathway

Homo sapiens
Sonic hedgehog is a protein that in humans is encoded by the SHH ("sonic hedgehog") gene.[5] Both the gene and the protein may also be found notated alternatively as "Shh". Sonic hedgehog is one of three proteins in the mammalian signaling pathway family called hedgehog, the others being desert hedgehog (DHH) and Indian hedgehog (IHH). SHH is the best studied ligand of the hedgehog signaling pathway. It plays a key role in regulating vertebrate organogenesis, such as in the growth of digits on limbs and organization of the brain. Sonic hedgehog is the best established example of a morphogen as defined by Lewis Wolpert's French flag model—a molecule that diffuses to form a concentration gradient and has different effects on the cells of the developing embryo depending on its concentration. SHH remains important in the adult. It controls cell division of adult stem cells and has been implicated in the development of some cancers.